Logo image of APTX

APTINYX INC (APTX) Stock News

NASDAQ:APTX - Nasdaq - US03836N1037 - Common Stock - Currency: USD

0.061  -0.04 (-39%)

After market: 0.074 +0.01 (+21.31%)

APTX Latest News, Press Relases and Analysis

News Image
2 years ago - InvestorPlace

Why Is Aptinyx (APTX) Stock Down 64% Today?

Aptinyx (APTX) stock is taking a beating on Tuesday after the company revealed poor results from a Phase 2 clinical trial.

Mentions: ILAG CBIO

News Image
2 years ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

It's time to start off the day with a breakdown of the biggest pre-market stock movers traders need to know about for Friday!

Mentions: DR PEAR TRKA TGL ...

News Image
2 years ago - InvestorPlace

AMC Stock Alert: AMC Entertainment Launches Popcorn Line at Walmart

AMC Entertainment (AMC) stock is in the news after the movie theater company announced it will launch its own line of popcorn at Walmart.

Mentions: AMC WMT AHCO ILAG

News Image
2 years ago - InvestorPlace

Why Is AdaptHealth (AHCO) Stock Down 22% Today?

AdaptHealth (AHCO) stock is falling on Tuesday following the release of the company's earnings report for the fourth quarter of 2022.

Mentions: AHCO ILAG CBIO

News Image
2 years ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

It's time to start the day with a breakdown of the biggest pre-market stock movers traders need to know about on Monday!

Mentions: CBIO ILAG EFTR ADMP ...

News Image
2 years ago - Seeking Alpha

APTX stock falls as Phase 2 trial for Parkinson's disease and dementia fails (NASDAQ:APTX)

Aptinyx (APTX) lost Tuesday after a setback for its Phase 2 trial for NYX-458 in cognitive impairment linked to Parkinson’s disease and dementia with Lewy bodies. Read the full story here.